Evogene Ltd (EVGN)
0.6369
-0.02
(-2.75%)
USD |
NASDAQ |
Apr 24, 12:31
Evogene Gross Profit Margin (Quarterly): 31.14% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 31.14% |
September 30, 2023 | 86.43% |
June 30, 2023 | 29.51% |
March 31, 2023 | 49.77% |
December 31, 2022 | 44.85% |
September 30, 2022 | 74.25% |
June 30, 2022 | 16.03% |
March 31, 2022 | 31.22% |
December 31, 2021 | 14.15% |
September 30, 2021 | 33.11% |
June 30, 2021 | 5.19% |
March 31, 2021 | 18.62% |
December 31, 2020 | 1.42% |
September 30, 2020 | 76.27% |
June 30, 2020 | 61.74% |
March 31, 2020 | 48.00% |
December 31, 2019 | 30.17% |
September 30, 2019 | 16.49% |
June 30, 2019 | 47.40% |
March 31, 2019 | 79.60% |
December 31, 2018 | 1.26% |
September 30, 2018 | 24.80% |
June 30, 2018 | 30.08% |
March 31, 2018 | 22.40% |
Date | Value |
---|---|
December 31, 2017 | 13.62% |
September 30, 2017 | 27.01% |
June 30, 2017 | 13.58% |
March 31, 2017 | 10.26% |
December 31, 2016 | 4.15% |
September 30, 2016 | 7.68% |
June 30, 2016 | 12.89% |
March 31, 2016 | 24.85% |
December 31, 2015 | 18.55% |
September 30, 2015 | 24.84% |
June 30, 2015 | 27.26% |
March 31, 2015 | 32.25% |
December 31, 2014 | 34.51% |
September 30, 2014 | 26.14% |
June 30, 2014 | 37.01% |
March 31, 2014 | 33.55% |
December 31, 2013 | 35.58% |
September 30, 2013 | 38.99% |
June 30, 2013 | 43.08% |
March 31, 2013 | 51.69% |
December 31, 2012 | 45.02% |
September 30, 2012 | 39.00% |
June 30, 2012 | 41.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
1.42%
Minimum
Dec 2020
86.43%
Maximum
Sep 2023
37.67%
Average
31.22%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -- |
BioLine Rx Ltd | -- |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -75.12% |
Return on Assets | -44.59% |
Return on Invested Capital | -56.76% |
Profit Margin (Quarterly) | -1.14K% |
Operating Margin (Quarterly) | -1.32K% |
Return on Net Operating Assets | -79.20% |